Induction of Human Trophoblast Stem Cells

Overview

Journal Nat Protoc

Specialties Biology
Pathology
Science

Date 2022 Oct 14

PMID 36241723

Authors

Gael Castel

Laurent David

Affiliations

Soon will be listed here.

Abstract

Cell reprogramming has allowed unprecedented access to human development, from virtually any genome. However, reprogramming yields pluripotent stem cells that can differentiate into all cells that form a fetus, but not extraembryonic annexes. Therefore, a cellular model allowing study of placental development from a broad genomic repertoire is lacking. Here, we describe an optimized protocol to reprogram somatic cells into human induced trophoblast stem cells (hiTSCs) and convert pluripotent stem cells into human converted TSCs (hcTSCs). This protocol enables much-needed genome-specific placental disease modeling. We also detail extravillous trophoblast and syncytiotrophoblast differentiation protocols from hiTSCs and hcTSCs, a necessary step to validate these cells. In total, this protocol takes 4 months and requires advanced cell culture skills, comparable to those necessary for somatic cell reprogramming into human induced pluripotent stem cells.

Citing Articles

Rapid retinoic acid-induced trophoblast cell model from human induced pluripotent stem cells.

Lemke K, Sarkar C, Azarin S Sci Rep. 2024; 14(1):18204.

PMID: 39107470 PMC: 11303561. DOI: 10.1038/s41598-024-68952-0.

Exploring maternal-fetal interface with in vitro placental and trophoblastic models.

Liu X, Wang G, Huang H, Lv X, Si Y, Bai L Front Cell Dev Biol. 2023; 11:1279227.

PMID: 38033854 PMC: 10682727. DOI: 10.3389/fcell.2023.1279227.

An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the Modeling of Placenta-Related Disorders.

Shum I, Merkert S, Malysheva S, Jahn K, Lachmann N, Verboom M Cells. 2023; 12(16).

PMID: 37626882 PMC: 10453333. DOI: 10.3390/cells12162070.

References

Okae H, Toh H, Sato T, Hiura H, Takahashi S, Shirane K . Derivation of Human Trophoblast Stem Cells. Cell Stem Cell. 2017; 22(1):50-63.e6. DOI: 10.1016/j.stem.2017.11.004. View

Turco M, Gardner L, Kay R, Hamilton R, Prater M, Hollinshead M . Trophoblast organoids as a model for maternal-fetal interactions during human placentation. Nature. 2018; 564(7735):263-267. PMC: 7220805. DOI: 10.1038/s41586-018-0753-3. View

Saha B, Ganguly A, Home P, Bhattacharya B, Ray S, Ghosh A . TEAD4 ensures postimplantation development by promoting trophoblast self-renewal: An implication in early human pregnancy loss. Proc Natl Acad Sci U S A. 2020; 117(30):17864-17875. PMC: 7395512. DOI: 10.1073/pnas.2002449117. View

Castel G, Meistermann D, Bretin B, Firmin J, Blin J, Loubersac S . Induction of Human Trophoblast Stem Cells from Somatic Cells and Pluripotent Stem Cells. Cell Rep. 2020; 33(8):108419. DOI: 10.1016/j.celrep.2020.108419. View

Amita M, Adachi K, Alexenko A, Sinha S, Schust D, Schulz L . Complete and unidirectional conversion of human embryonic stem cells to trophoblast by BMP4. Proc Natl Acad Sci U S A. 2013; 110(13):E1212-21. PMC: 3612666. DOI: 10.1073/pnas.1303094110. View

Krendl C, Shaposhnikov D, Rishko V, Ori C, Ziegenhain C, Sass S . GATA2/3-TFAP2A/C transcription factor network couples human pluripotent stem cell differentiation to trophectoderm with repression of pluripotency. Proc Natl Acad Sci U S A. 2017; 114(45):E9579-E9588. PMC: 5692555. DOI: 10.1073/pnas.1708341114. View

Horii M, Li Y, Wakeland A, Pizzo D, Nelson K, Sabatini K . Human pluripotent stem cells as a model of trophoblast differentiation in both normal development and disease. Proc Natl Acad Sci U S A. 2016; 113(27):E3882-91. PMC: 4941448. DOI: 10.1073/pnas.1604747113. View

Horii M, Morey R, Bui T, Touma O, Nelson K, Cho H . Modeling preeclampsia using human induced pluripotent stem cells. Sci Rep. 2021; 11(1):5877. PMC: 7961010. DOI: 10.1038/s41598-021-85230-5. View

Sheridan M, Yang Y, Jain A, Lyons A, Yang P, Brahmasani S . Early onset preeclampsia in a model for human placental trophoblast. Proc Natl Acad Sci U S A. 2019; 116(10):4336-4345. PMC: 6410818. DOI: 10.1073/pnas.1816150116. View

10.

Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F . Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell. 2014; 158(6):1254-1269. PMC: 4162745. DOI: 10.1016/j.cell.2014.08.029. View

11.

Yang Y, Liu B, Xu J, Wang J, Wu J, Shi C . Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency. Cell. 2017; 169(2):243-257.e25. PMC: 5679268. DOI: 10.1016/j.cell.2017.02.005. View

12.

Amit M, Carpenter M, Inokuma M, Chiu C, Harris C, Waknitz M . Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 2000; 227(2):271-8. DOI: 10.1006/dbio.2000.9912. View

13.

Zhou J, West R, Ehlers E, Ezashi T, Schulz L, Roberts R . Modeling human peri-implantation placental development and function†. Biol Reprod. 2021; 105(1):40-51. PMC: 8256105. DOI: 10.1093/biolre/ioab080. View

14.

Horii M, Touma O, Bui T, Parast M . Modeling human trophoblast, the placental epithelium at the maternal fetal interface. Reproduction. 2020; 160(1):R1-R11. PMC: 7286067. DOI: 10.1530/REP-19-0428. View

15.

Moser G, Weiss G, Gauster M, Sundl M, Huppertz B . Evidence from the very beginning: endoglandular trophoblasts penetrate and replace uterine glands in situ and in vitro. Hum Reprod. 2015; 30(12):2747-57. PMC: 4719185. DOI: 10.1093/humrep/dev266. View

16.

Moser G, Weiss G, Sundl M, Gauster M, Siwetz M, Lang-Olip I . Extravillous trophoblasts invade more than uterine arteries: evidence for the invasion of uterine veins. Histochem Cell Biol. 2016; 147(3):353-366. PMC: 5344955. DOI: 10.1007/s00418-016-1509-5. View

17.

Moser G, Drewlo S, Huppertz B, Armant D . Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies. Hum Reprod Update. 2018; 24(4):484-496. PMC: 6016716. DOI: 10.1093/humupd/dmy008. View

18.

Papuchova H, Kshirsagar S, Xu L, Bougleux Gomes H, Li Q, Iyer V . Three types of HLA-G+ extravillous trophoblasts that have distinct immune regulatory properties. Proc Natl Acad Sci U S A. 2020; 117(27):15772-15777. PMC: 7355041. DOI: 10.1073/pnas.2000484117. View

19.

Pollheimer J, Vondra S, Baltayeva J, Beristain A, Knofler M . Regulation of Placental Extravillous Trophoblasts by the Maternal Uterine Environment. Front Immunol. 2018; 9:2597. PMC: 6243063. DOI: 10.3389/fimmu.2018.02597. View

20.

Borbely A, Sandri S, Fernandes I, Prado K, Cardoso E, Correa-Silva S . The term basal plate of the human placenta as a source of functional extravillous trophoblast cells. Reprod Biol Endocrinol. 2014; 12:7. PMC: 3909387. DOI: 10.1186/1477-7827-12-7. View